Rayonier IncRYN
Price$18.22Intrinsic value$24.7336% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $676.9M-31.4% YoYTTM through 31 Mar 2026
Net Income $465.4M+29.6% YoYTTM through 31 Mar 2026
Free Cash Flow $194.8MTTM through 31 Mar 2026

Margins

Current
Operating Margin17.2%
Net Margin68.8%

Returns

21.5%ROE
6.0%ROA
6.9%ROIC

Balance Sheet Health

Debt / Equity0.48x
Current Ratio2.53x
Net Debt$207.1M
Cash & Equivalents$681.7M

Quality Metrics

Altman Z-Score1.72
Piotroski F-Score3 / 9
FCF Margin28.8%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $484.5M
Diluted EPS$3.00TTM
'19'20'21'22'23'24'25
FY2025: $3.03

Dividend

$2.21Per share, FY202610.90%Yield+15.4%5-yr growth

Capital Allocation

Capex Intensity10.2%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.